Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jun:43:85-94.
doi: 10.1016/j.nutos.2022.05.007. Epub 2022 May 28.

Retinol Depletion in COVID-19

Affiliations

Retinol Depletion in COVID-19

Aziz Rodan Sarohan et al. Clin Nutr Open Sci. 2022 Jun.

Abstract

Background and aims: COVID-19 has been a devastating pandemic. There are indications that vitamin A is depleted during infections. Vitamin A is important in development and immune homeostasis. It has been used successfully in measles, RSV and AIDS infections. In this study, we aimed to measure the serum retinol levels in severe COVID-19 patients to assess the importance of vitamin A in the COVID-19 pathogenesis.

Methods: The serum retinol level was measured in two groups of patients: the COVID-19 group, which consisted of 27 severe COVID-19 patients hospitalized in the intensive care unit with respiratory failure, and the control group, which consisted of 23 patients without COVID-19 symptoms.

Results: The mean serum retinol levels were 0.37 mg/L in the COVID-19 group and 0.52 mg/L in the control group. The difference between the serum retinol levels in the two groups was statistically significant. There was no significant difference in retinol levels between different ages and genders within the COVID-19 group. Comorbidity did not affect serum retinol levels.

Conclusion: The serum retinol level was significantly lower in patients with severe COVID-19, and this difference was independent of age or underlying comorbidity. Our data show that retinol and retinoic acid signaling might be important in immunopathogenesis of COVID-19.

Keywords: COVID-19; Retinoic acid; Retinol; SARS-CoV2; Type-I IFN; Vitamin A.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest. No author is affiliated with any undeclared institution or financial relationship that could affect the objectivity of this study.

Similar articles

Cited by

References

    1. Olwenyi O.A., Dyavar S.R., Acharya A., Podany A.T., Fletcher C.V., Ng C.L., et al. Immuno-epidemiology and pathophysiology of coronavirus disease 2019 (COVID-19) J Molecul Med (Berlin, Germany) 2020;98(10):1369–1383. - PMC - PubMed
    1. Jin Y., Yang H., Ji W., Wu W., Chen S., Zhang W., et al. Virology, Epidemiology, Pathogenesis, and Control of COVID-19. Viruses. 2020;12(4) - PMC - PubMed
    1. WHO. WHO coronovirus (COVID-19) dashboard [website]. World Health Organization; [updated 12/09/2021. Available from: https://covid19.who.int/.
    1. Chung J.Y., Thone M.N., Kwon Y.J. COVID-19 vaccines: The status and perspectives in delivery points of view. Adv Drug Delivery Rev. 2021;170:1–25. - PMC - PubMed
    1. Krammer F. SARS-CoV-2 vaccines in development. Nature. 2020;586(7830):516–527. - PubMed